The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study

about

The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study

Item

http://www.wikidata.org/entity/Q35916166

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The impact of chemotherapy dos ...... er: a prospective cohort study

@ast

The impact of chemotherapy dos ...... er: a prospective cohort study

@en

type

Item

label

The impact of chemotherapy dos ...... er: a prospective cohort study

@ast

The impact of chemotherapy dos ...... er: a prospective cohort study

@en

prefLabel

The impact of chemotherapy dos ...... er: a prospective cohort study

@ast

The impact of chemotherapy dos ...... er: a prospective cohort study

@en

P1476

The impact of chemotherapy dos ...... er: a prospective cohort study

@en

P2093

David C Dale

http://www.w3.org/2001/XMLSchema#string

Debra A Wolff

http://www.w3.org/2001/XMLSchema#string

Eva Culakova

http://www.w3.org/2001/XMLSchema#string

Gary H Lyman

http://www.w3.org/2001/XMLSchema#string

Jeffrey Crawford

http://www.w3.org/2001/XMLSchema#string

Marek S Poniewierski

http://www.w3.org/2001/XMLSchema#string

P2860

Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study

Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer.

Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.

The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study.

Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

P2888

s40064-015-1165-6

P304

396

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40064-015-1165-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280910304

http://www.w3.org/2001/XMLSchema#string

P6179

1021254417

http://www.w3.org/2001/XMLSchema#string

P698

26251780

http://www.w3.org/2001/XMLSchema#string

P932

4524886

http://www.w3.org/2001/XMLSchema#string